Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2011
The importance of doing trials right while doing the right trialsDavid M Dilts, Steven K ChengClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
Predicting accrual achievement: monitoring accrual milestones of NCI-CTEP-sponsored clinical trialsSteven K Cheng, Mary S Dietrich, David M DiltsClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2010
A sense of urgency: Evaluating the link between clinical trial development time and the accrual performance of cancer therapy evaluation program (NCI-CTEP) sponsored studiesSteven K Cheng, Mary S Dietrich, David M DiltsAcademic Medicine : Journal of the Association of American Medical Colleges|September 29, 2011
The prevalence and economic impact of low-enrolling clinical studies at an academic medical centerDarlene R Kitterman, Steven K Cheng, David M Dilts, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2010
Phase III clinical trial development: a process of chutes and laddersDavid M Dilts, Steven K Cheng, Joshua S Crites, et al.JAMA Internal Medicine|May 24, 2013
Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.govBradford R Hirsch, Robert M Califf, Steven K Cheng, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Steps and time to process clinical trials at the Cancer Therapy Evaluation ProgramDavid M Dilts, Alan B Sandler, Steven K Cheng, et al.Lung Cancer (Amsterdam, Netherlands)|March 21, 2022
Biomarker testing and tissue journey among patients with metastatic non-small cell lung cancer receiving first-line therapy in The US Oncology NetworkNicholas J Robert, Janet L Espirito, Liwei Chen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group BDavid M Dilts, Alan B Sandler, Matthew Baker, et al.Pageof 1